Source of human oocytes for infertility treatment and fertility preservation. Issue 1 (March 2022)

• Record Type: Journal Article
• Authors: Chian, Ri-Cheng
• Is Part Of: Reproductive and developmental medicine. Volume 6:Issue 1(2022)
• Page Start: 6
• Page End: 12
• Publication Date: 2022-03
• Subjects: Oocytes -- Infertility -- Fertility preservation -- Ovarian stimulation -- Live birth; Reproductive Physiological Phenomena; Reproductive Techniques; Reproductive Medicine; Developmental Biology; Reproductive health; Developmental biology; Electronic journals; Periodical; Periodicals; 612.6
• DOI: 10.1097/RD9.0000000000000007
• Languages: English
• ISSNs: 2096-2924

Abstract

Abstract : Abstract: The source of human oocytes is directly associated with the success of infertility treatment and fertility preservation. The number of oocytes obtained is possibly correlated with the success rate in terms of live birth rates. However, oocyte quality must be refined such that the number of oocytes is not positively correlated with the quality of oocytes. Different ovarian stimulation protocols can be used to obtain numerous oocytes. However, oocyte quality should be considered the most important factor affecting infertility treatment and fertility preservation. Infertile women are generally willing to take health-related risks to achieve a live birth, and ovarian stimulation using high-dose hormonal treatments may be harmful for both women and infants. Therefore, successful infertility treatment and fertility preservation should be defined as the birth of a healthy baby at term without compromising the health and safety of the mother and infant. Therefore, the source of high-quality oocytes must be carefully considered prior to infertility treatment and fertility preservation.